본문 바로가기
KERD
논문KCI 등재

Benign Multiple Sclerosis is Associated with Reduced Tinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background and Purpose It is exceedingly difcult to diferentiate benign multiple sclerosis (BMS) from relapsing-remitting multiple sclerosis (RRMS) based on clinical characteristics, neuroimaging, and cerebrospinal fuid tests. Optical coherence tomography (OCT) allows quantifcation of retinal structures, such as the retinal nerve fber layer (RNFL) thickness, at the optic disc and the ganglion cell layer (GCL) at the macula, on a micrometer scale. It can also be used to trace minor alterations and the progression of neurodegeneration, help predict BMS, and infuence the choice of therapy. To utilize OCT to detect the extent of changes of the optic disk and macular microstructure in patients with BMS and RRMS compared to healthy controls (HCs), with special focus on changes related to the presence/absence of optic neuritis (ON). Methods Spectral-domain OCT was applied to examine eyes from 36 patients with multiple sclerosis (MS), comprising 11 with BMS and 25 with RRMS, and 34 HCs. Results Te RNFL and GCL were signifcantly thinner in eyes previously afected by ON, irrespective of the type of MS (i.e., BMS or RRMS), than in HCs. Signifcant thinning of the GCL was also observed in non-ON RRMS (and not non-ON BMS) compared to HCs. Correspondingly, a signifcant association between disease duration and thinning rates of the RNFL and GCL was observed only in non-ON RRMS (-0.54±0.24 and -0.43±0.21 μm/year, mean± SE; p<0.05 for both), and not in non-ON BMS (-0.11±0.27 and -0.24±0.24 μm/year). Conclusions Te RNFL and GCL were thinner in both ON- and non-ON MS, but the change was more pronounced in ON MS, irrespective of the MS subtype studied herein. GCL thinning and the thinning rate of both the GCL and RNFL were less pronounced in non-ON BMS than in non-ON RRMS. Tese fndings may help to predict the course of BMS.

Abstract

Background and Purpose It is exceedingly difcult to diferentiate benign multiple sclerosis (BMS) from relapsing-remitting multiple sclerosis (RRMS) based on clinical characteristics, neuroimaging, and cerebrospinal fuid tests. Optical coherence tomography (OCT) allows quantifcation of retinal structures, such as the retinal nerve fber layer (RNFL) thickness, at the optic disc and the ganglion cell layer (GCL) at the macula, on a micrometer scale. It can also be used to trace minor alterations and the progression of neurodegeneration, help predict BMS, and infuence the choice of therapy. To utilize OCT to detect the extent of changes of the optic disk and macular microstructure in patients with BMS and RRMS compared to healthy controls (HCs), with special focus on changes related to the presence/absence of optic neuritis (ON). Methods Spectral-domain OCT was applied to examine eyes from 36 patients with multiple sclerosis (MS), comprising 11 with BMS and 25 with RRMS, and 34 HCs. Results Te RNFL and GCL were signifcantly thinner in eyes previously afected by ON, irrespective of the type of MS (i.e., BMS or RRMS), than in HCs. Signifcant thinning of the GCL was also observed in non-ON RRMS (and not non-ON BMS) compared to HCs. Correspondingly, a signifcant association between disease duration and thinning rates of the RNFL and GCL was observed only in non-ON RRMS (-0.54±0.24 and -0.43±0.21 μm/year, mean± SE; p<0.05 for both), and not in non-ON BMS (-0.11±0.27 and -0.24±0.24 μm/year). Conclusions Te RNFL and GCL were thinner in both ON- and non-ON MS, but the change was more pronounced in ON MS, irrespective of the MS subtype studied herein. GCL thinning and the thinning rate of both the GCL and RNFL were less pronounced in non-ON BMS than in non-ON RRMS. Tese fndings may help to predict the course of BMS.

참고문헌 (30)

  1. Pittock SJ, "Clinical implications of benign multiple sclerosis:a 20-year population-based follow-up study", Ann Neurol, 56, pp.303~306 (2004)
  2. Sayao AL, "Longitudinal follow-up of “benign”multiple sclerosis at 20 years", Neurology, 68, pp.496~500 (2007)
  3. Hirst C, "Increasing prevalence and incidence of multiple sclerosis in South East Wales", J Neurol Neurosurg Psychiatry, 80, pp.386~391 (2009)
  4. Glad SB, "Benign multiple sclerosis: a need for a consensus", Acta Neurol Scand Suppl, 190, pp.44~50 (2010)
  5. Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", Neurology, 33, pp.1444~1452 (1983)
  6. Goodin DS, "Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines", Neurology, 58, pp.169~178 (2002)
  7. Comi G, "Clinically isolated syndrome: the rationale for early treatment", Nat Clin Pract Neurol, 4, pp.234~235 (2008)
  8. Parisi V, "Correlation between morphological and functional retinal impairment in multiple sclerosis patients", Invest Ophthalmol Vis Sci, 40, pp.2520~2527 (1999)
  9. Costello F, "Quantifying axonal loss after optic neuritis with optical coherence tomography", Ann Neurol, 59, pp.963~969 (2006)
  10. Gallo A, "Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis", Neurology, 79, pp.1458~1465 (2012)
  11. Klistorner A, "Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential", Neurology, 80, pp.242~245 (2013)
  12. Sriram P, "Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients", PLoS One, 9, pp.e102546~ (2014)
  13. Oberwahrenbrock T, "Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome", Mult Scler, 19, pp.1887~1895 (2013)
  14. Oberwahrenbrock T, "Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography", Mult Scler Int, 2012, pp.530305~ (2012)
  15. Ratchford JN, "Active MS is associated with accelerated retinal ganglion cell", inner plexiform layer thinning, 2013, pp.80, 47~54
  16. Nolan R, "Fingolimod treatment in multiple sclerosis leads to increased macular volume", Neurology, 80, pp.139~144 (2013)
  17. Winges KM, "Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis", J Neuroophthalmol, 33, pp.322~329 (2013)
  18. Dinkin M, "Higher macular volume in patients with MS receiving fingolimod: positive outcome or side effect?", Neurology, 80, pp.128~129 (2013)
  19. Galetta KM, "Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study", J Neuroophthalmol, 32, pp.116~123 (2012)
  20. Lange AP, "Retinal nerve fiber layer thickness in benign multiple sclerosis", Mult Scler, 19, pp.1275~1281 (2013)
  21. Polman CH, "Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”", Ann Neurol, 58, pp.840~846 (2005)
  22. Link H, "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness", J Neuroimmunol, 180, pp.17~28 (2006)
  23. Walter SD, "Ganglion cell loss in relation to visual disability in multiple sclerosis", Ophthalmology, 119, pp.1250~1257 (2012)
  24. Prasad S, "Anatomy and physiology of the afferent visual system", Handb Clin Neurol, 102, pp.3~19 (2011)
  25. Fisher JB, "Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis", Ophthalmology, 113, pp.324~332 (2006)
  26. Saidha S, "Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis", JAMA Neurol, 70, pp.34~43 (2013)
  27. Syc SB, "Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis", Brain, 135(2), pp.521~533 (2012)
  28. Martínez-Lapiscina EH, "Colour vision impairment is associated with disease severity in multiple sclerosis", Mult Scler, 20, pp.1207~1216 (2014)
  29. Keller J, "Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells", PLoS One, 9, pp.e97444~ (2014)
  30. Harwerth RS, "Age-related losses of retinal ganglion cells and axons", Invest Ophthalmol Vis Sci, 49, pp.4437~4443 (2008)

관련 논문AI추천

Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography StudyAldo Vagge, Alessandro Masala, Antonio Uccelli, Carlo E Traverso, Cordano Christian, Ilaria Di Mola, Maria Cellerino, Michele Iester, Valentina Pera대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제3호Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder김남희, 김호진, 박철용, 정경숙, 조중양대한신경과학회 · Journal of Clinical Neurology2018 · 제14권 제2호Recurrent Optic Neuritis as the Initial Symptom in Demyelinating DiseasesAlessandra Billi, Denis Bernardi Bichuetti, Enedina Maria Lobato de Oliveira, Falcão-Gonçalves대한신경과학회 · Journal of Clinical Neurology2018 · 제14권 제3호Longitudinal Changes in the Retinal Nerve Fiber Layer Thickness in Amyotrophic Lateral Sclerosis and Parkinson’s DiseaseAi Huey Tan, Mohd Taufiq Abdul Ghani, Norlina Ramli, Nortina Shahrizaila, Sharifah Azira Taufik, Shen-Yang Lim대한신경과학회 · Journal of Clinical Neurology2024 · 제20권 제3호Analysis of the Retinal Nerve Fiber Layer Thickness in Alzheimer Disease and Mild Cognitive Impairment권진영, 김도균, 양지호, 한지상대한안과학회 · Korean Journal of Ophthalmology2017 · 제31권 제6호Orbital Doppler Evaluation of Blood Flow Velocities in Optic NeuritisAlireza Dehghani, Maryam Riahinejad, Mehdi Karami, Mohsen Janghorbani대한안과학회 · Korean Journal of Ophthalmology2012 · 제26권 제2호

이 간행물의 다른 논문 (15건)